Glycopeptides with TN antigen (GaINAc)Ser/Thr and T-antigen structures (I3Gall-3GalNAc)Ser/Thr, described as tumor-associated antigens, were synthesized and coupled to bovine serum albumin. Alternatively, synthetic methods for the construction of 13-anomeric analogues of the TN and T-antigen glycopeptides were developed, aiming at antigenic structures having a varied stereochemistry of the linkage between the carbohydrate and the peptide moiety. As a further type of potential tumor-associated antigen, fucosyl-chitobiose asparagine glycopeptides were synthesized, deprotected, and coupled to bovine serum albumin. The chemical methods developed now make the complex sensitive glycoprotein partial structures accessible in analytically pure form and in preparative amounts.
Introduction
Carbohydrate structures of the outer cell membrane glycoproteins are suspected to exhibit decisive functions in intercellular communication and in the regulation of cell growth (1) . In agreement with this molecular mechanistic aspect, it has been found that abnormal cell growth and tumor development parallel a dramatic change in the structures of membrane glycoproteins (2) . The altered glycoproteins of the tumor cell membranes seem to be tumor-associated antigens. In this sense, Springer and colleagues reported in a number of articles that glycoproteins of the TN and T-antigen type represent tumor-associated antigen structures (3) (Fig. 1 logical sources often causes serious difficulties in immunological applications and leads to irreproducible effects. Recent results of investigations on tumor-associated immunodeterminant glyean structures suggest that the T-antigen disaccharide analogue with ,B-anomeric configuration at the penultimate galactosamine unit, rather than the natural T-antigen 2 itself, shows a tumor-associated reactivity (6) . Therefore, we changed the concept ofthe glycopeptide syntheses and now aimed at structures containing galactosamine 3-glycosidically linked to serine or threonine. The synthesis of glycoconjugates with these structural fea- (Fig. 3) .
In spite of the non-neighboring group active protection of the glycosyl donor 5, the 13-anomeric conjugate is obtained selectively. The method is of fundamental importance for the projected syntheses of Fucosyl Chitobiose-Asparagine Glycopeptides N-Glycoproteins fucosylated in the core region have also been suspected to be structures associated with tumor membranes (7) . Therefore, glycopeptides of type 8 (Fig. 4) were selected as another goal in our syntheses of antigenic structures.
The synthesis of the branched fucosylated chitobiosyl amine requires some 20 steps. During the further processing of the trisaccharide asparagine conjugate 9 (Fig.  5) , the allyloxycarbonyl (Aloc) protecting group was revealed to be a very efficient and selective tool (8) . It is removable quite selectively and almost quantitatively by means of a palladium-catalyzed allyl transfer to the weakly basic morpholine. Subsequent chain extension yielded the trisaccharide tripeptide 10 (Fig. 5) , a structure which is part of an influenza virus neuraminidase. The projected removal of the C-terminal tert-butyl ester protection, a precondition for the immunological evaluation of the synthetic glycopeptide, was shown to be impossible.
The treatment of compounds like 10 ( Fig. 5 ) with trifluoroacetic acid resulted in complete cleavage of the fucoside bond. To overcome this serious problem in the synthesis of fucosylated glycopeptides, a new trisaccharide synthesis was elaborated. It aimed at the synthesis of a saccharide asparagine conjugate 11 (Fig. 6 ) that exclusively carries acetyl protecting groups in the carbohydrate moiety.
The synthesis of conjugate 11 requires almost 30 steps. The useful Aloc protecting method allowed a highly efficient and selective deblocking and N-terminal chain extension. The selective cleavage of the C-terminal tert-butyl ester of the resulting trisaccharide tripeptide using trifluoroacetic acid was now achieved without destruction of the fucoside bond. The selectively deblocked product could be condensed efficiently with a tripeptide ester to form the corresponding trisaccharide hexapeptide, a protected partial sequence of an envelope glycoprotein of a murine leukemia virus.
Further C-terminal deprotection and removal of the ester groups from the carbohydrate part delivered the free fucosyl chitobiose glycopeptide 12, which is interesting as a virus envelope structure as well as a potential tumor-associated antigen. Glycopeptide 12 was then coupled to bovine serum albumin by applying the method elaborated for the T-antigen glycopeptide. The conjugate obtained contains about 12% carbohydrate. It is currently being investigated for immunological applications.
